Literature DB >> 25592652

Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Carole Dangoisse1, Helen Dickie, Linda Tovey, Marlies Ostermann.   

Abstract

BACKGROUND: Severe hyper- and hyponatraemia is associated with significant risks, yet its correction can also have serious consequences when implemented too fast or inadequately. The safe correction of serum sodium levels is particularly challenging when renal replacement therapy (RRT) is required.
METHODS: Using 2 case scenarios, we aim to illustrate a simple method of correcting hyper- and hyponatraemia safely by step-wise manipulation of the dialysate/replacement fluid.
RESULTS: During continuous RRT, hypernatraemia can be corrected effectively and safely by adding small pre-calculated amounts of 30% NaCl to the dialysate/replacement fluid bags aiming for a [Na(+)] in the fluid that allows safe equilibration and correction of the serum [Na(+)]. To correct hyponatraemia safely, pre-calculated amounts of sterile water can be added in a step-wise manner to achieve a fluid [Na(+)] that equals the desired target serum [Na(+)].
CONCLUSION: During continuous RRT, the step-wise adjustment of [Na(+)] of dialysate/replacement fluids offers a safe and reliable method to correct sodium disorders.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592652     DOI: 10.1159/000369347

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  9 in total

1.  Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Authors:  E Sbardella; A M Isidori; G Arnaldi; M Arosio; C Barone; A Benso; R Berardi; G Capasso; M Caprio; F Ceccato; G Corona; S Della Casa; L De Nicola; M Faustini-Fustini; E Fiaccadori; L Gesualdo; S Gori; A Lania; G Mantovani; P Menè; G Parenti; C Pinto; R Pivonello; P Razzore; G Regolisti; C Scaroni; F Trepiccione; A Lenzi; A Peri
Journal:  J Endocrinol Invest       Date:  2017-11-20       Impact factor: 4.256

2.  Management of Severe Hyponatremia with Continuous Renal Replacement Therapies.

Authors:  Mitchell H Rosner; Michael J Connor
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-20       Impact factor: 8.237

Review 3.  Acute Kidney Injury at the Neurocritical Care Unit.

Authors:  Gonzalo Ramírez-Guerrero; Romyna Baghetti-Hernández; Claudio Ronco
Journal:  Neurocrit Care       Date:  2021-09-13       Impact factor: 3.210

Review 4.  Sodium-Based Osmotherapy in Continuous Renal Replacement Therapy: a Mathematical Approach.

Authors:  Jerry Yee; Naushaba Mohiuddin; Tudor Gradinariu; Junior Uduman; Stanley Frinak
Journal:  Kidney360       Date:  2020-02-26

5.  Severe Hyponatremia and Continuous Renal Replacement Therapy: Safety and Effectiveness of Low-Sodium Dialysate.

Authors:  Srijan Tandukar; Catherine Kim; Kartik Kalra; Siddharth Verma; Paul M Palevsky; Chethan Puttarajappa
Journal:  Kidney Med       Date:  2020-06-15

6.  Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum.

Authors:  Paul Secombe; Chris Milne
Journal:  BMJ Case Rep       Date:  2016-12-13

7.  Insights about serum sodium behavior after 24 hours of continuous renal replacement therapy.

Authors:  Thiago Gomes Romano; Cassia Pimenta Barufi Martins; Pedro Vitale Mendes; Bruno Adler Maccagnan Pinheiro Besen; Fernando Godinho Zampieri; Marcelo Park
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

Review 8.  Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment.

Authors:  Soraya Arzhan; Susie Q Lew; Todd S Ing; Antonios H Tzamaloukas; Mark L Unruh
Journal:  Front Med (Lausanne)       Date:  2021-12-06

9.  Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy.

Authors:  Song In Baeg; Junseok Jeon; Danbee Kang; Soo Jin Na; Juhee Cho; Kyunga Kim; Jeong Hoon Yang; Chi Ryang Chung; Jung Eun Lee; Wooseong Huh; Gee Young Suh; Yoon-Goo Kim; Dae Joong Kim; Hye Ryoun Jang
Journal:  Front Med (Lausanne)       Date:  2022-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.